Finally, in the simulated colorectal tumor data for the eight patients, we demonstrated the robustness of REOs against PTEC variations by analyzing two genes, SFRP1 remarkably under-expressed in colorectal tumor tissues [34] and ACTA2 over-expressed in malignant colorectal tumor stromal cells [35]. This evidence concerns the gene SFRP1 and colorectal neoplasm.